Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Basal Cell × Imiquimod × Clear all

Phase

Phase 4 4 Phase 3 4 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 5 Uterine Cervical Neoplasms 3 Uterine Cervical Dysplasia 2 Papillomavirus Infections 2 Melanoma 2 Hemangioma, Capillary 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Skin Neoplasms 1 Sexually Transmitted Diseases 1 Precancerous Conditions 1 Pigmentation Disorders 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hemangioma 1 HPV 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Condylomata Acuminata 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Basal Cell 1 Carcinoma in Situ 1

Interventions

HhAntag691 13 Aminolevulinic Acid 5 sonidegib 4 Nivolumab 3 tazarotene 2 daromun 2 cemiplimab 2 Specimen Handling 2 Radiotherapy 2 IPI-926 2 Drug Evaluation 2 Celecoxib 2 3-ingenyl angelate 2 talimogene laherparepvec 1 remetinostat 1 relatlimab 1 endonuclease V, phage T4 1 Triamcinolone 1 Sutures 1 Surgical Procedures, Operative 1 Solutions 1 Papillomavirus Vaccines 1 Opdualag 1 Niacinamide 1 NVP-BKM120 1 Methotrexate 1 Magnetic Resonance Spectroscopy 1 Lighting 1 Ipilimumab 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03534947 2025-12-16

SONIB

Melanoma Institute Australia

Phase 2 Completed

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡